Home > Maligne hematologie > Lymfoïde ziekten > Acute lymfatische leukemie (ALL) en lymfoblastair lymfoom (LBL) > AMG360

Printen

Versie:
Revisie:	20-11-2023
Type:	Studie
Status:	Open
Ziektebeeld:	Acute lymfatische leukemie (ALL) en lymfoblastair lymfoom (LBL)
Behandellijn:	1ste lijn
Fase:	Fase 3
Leeftijd:
PI:	Dr. T. van Meerten
TC:	Maryleen van Zanten
Titel:	Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)

AMG360

Studieprotocol

ICF

Aanvullende documenten

Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study) https://research.monash.edu/en/projects/phase-3-randomized-controlled-study-of-blinatumomab-alternating-w